26 results
8-K
EX-10.2
FBIO
Fortress Biotech Inc
3 Jan 24
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:10pm
such Indemnified Person and the Company, and such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual conflict … of interest that prevents the counsel selected by the Company from representing both the Company (or another client of such counsel) and any
8-K
EX-10.2
FBIO
Fortress Biotech Inc
14 Nov 23
Fortress Biotech Announces Launch of Proposed Public Offering
4:11pm
and the Company, and such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual conflict of interest
8-K
EX-10.1
FBIO
Fortress Biotech Inc
19 Dec 22
Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
8:26am
person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company … be a conflict of interest between the Company and Indemnitee in the conduct of any such defense or the Company shall not, in fact, have employed counsel
424B5
5358thcwvz
28 Aug 20
Prospectus supplement for primary offering
8:45am
8-K
EX-1.1
o93lr rzgv8eip6
28 Aug 20
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
8:10am
424B5
5cvcl
24 Aug 20
Prospectus supplement for primary offering
8:01am
8-K
EX-1.1
ltgk 4xv13jdo2y9gbfl
29 May 20
Other Events
5:06pm
8-K
EX-1.1
rlrn8 nhk
28 May 20
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
5:07pm
424B5
bgqqee6bue njxse
28 May 20
Prospectus supplement for primary offering
5:01pm
424B5
wf8rpa ao
19 May 20
Prospectus supplement for primary offering
5:14pm
424B5
k97wd
12 Feb 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-10.1
h7r409tlfoxup3d9tv
12 Feb 20
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
5:21pm
424B5
75zncd
27 Jan 20
Prospectus supplement for primary offering
8:31am
8-K
EX-10.1
21tec
26 Nov 19
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
5:26pm
424B5
5t4y9ckwxdbsugpetgeo
26 Nov 19
Prospectus supplement for primary offering
5:25pm
424B5
d6v3dnhiuz6
12 Nov 19
Prospectus supplement for primary offering
7:47am